Download PDF
Semin Reprod Med 2014; 32(01): 023-027
DOI: 10.1055/s-0033-1361819
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Microbiome and Probiotics in Childhood

Michael Harrison Hsieh
1   Department of Urology, Stanford University School of Medicine, Stanford University, Stanford, California
› Author Affiliations
Further Information

Publication History

Publication Date:
03 January 2014 (online)

    Permissions and Reprints

Abstract

Infants, from the moment of birth, are colonized by large numbers of microbes. This colonization continues throughout childhood and from preliminary studies seems to be a highly dynamic process, even during the usual physiologic state we refer to as health. In this context, the persistence of bacterial and fungal species in and on the human body likely confers various benefits to the host. One specific approach to modulate such beneficial effects is the administration of probiotics, also known as beneficial microbes. Herein, we outline the highest level evidence in regard to the evolution of the microbiome during childhood and its manipulation by probiotics for genitourinary, enteric, and allergic and atopic disorders. Thus, probiotic approaches are promising alternatives and adjuvants to traditional vaccines and antibiotics. This may usher in a new age in which vaccine and antibiotic side effects and antibiotic resistance are minimal issues in the setting of maintaining children's health and prevention of disease.

Keywords

probiotics - children - microbiome
 

  • References

  • 1 Guidelines for the Evaluation of Probiotics in Food. Geneva, Switzerland: the Food and Agriculture Organization of the United Nations and World Health Organization; 2002: 1-11
    Google Scholar
  • 2 Tierno PM. The Secret Life of Germs. New York: Atria; 2001
    Google Scholar
  • 3 Paustian T. The normal flora of humans. In: Paustian T, , ed. Microbiology and Bacteriology: The World of Microbes. Madison, WI: University of Wisconsin-Madison; 2006
    Google Scholar
  • 4 Rolfe RD. Interactions among microorganisms of the indigenous intestinal flora and their influence on the host. Rev Infect Dis 1984; 6 (Suppl. 01) S73-S79
    CrossrefPubMedGoogle Scholar
  • 5 Wucherpfennig KW. Structural basis of molecular mimicry. J Autoimmun 2001; 16 (3) 293-302
    CrossrefPubMedGoogle Scholar
  • 6 Nackerdien ZE. Perspectives on microbes as oncogenic infectious agents and implications for breast cancer. Med Hypotheses 2008; 71 (2) 302-306
    CrossrefPubMedGoogle Scholar
  • 7 Giaffer MH, Holdsworth CD, Duerden BI. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 1991; 35 (4) 238-243
    CrossrefPubMedGoogle Scholar
  • 8 Barbara G, Stanghellini V, Brandi G , et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005; 100 (11) 2560-2568
    CrossrefPubMedGoogle Scholar
  • 9 Quigley EM. Germs, gas and the gut; the evolving role of the enteric flora in IBS. Am J Gastroenterol 2006; 101 (2) 334-335
    CrossrefPubMedGoogle Scholar
  • 10 Vaishampayan PA, Kuehl JV, Froula JL, Morgan JL, Ochman H, Francino MP. Comparative metagenomics and population dynamics of the gut microbiota in mother and infant. Genome Biol Evol 2010; 2: 53-66
    CrossrefPubMedGoogle Scholar
  • 11 Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5 (7) e177
    CrossrefPubMedGoogle Scholar
  • 12 Murgas Torrazza R, Neu J. The developing intestinal microbiome and its relationship to health and disease in the neonate. J Perinatol 2011; 31 (Suppl. 01) S29-S34
    CrossrefPubMedGoogle Scholar
  • 13 Douglas-Escobar M, Elliott E, Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr 2013; 167 (4) 374-379
    CrossrefPubMedGoogle Scholar
  • 14 Buccigrossi V, Nicastro E, Guarino A. Functions of intestinal microflora in children. Curr Opin Gastroenterol 2013; 29 (1) 31-38
    CrossrefPubMedGoogle Scholar
  • 15 Perez PF, Doré J, Leclerc M , et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells?. Pediatrics 2007; 119 (3) e724-e732
    CrossrefPubMedGoogle Scholar
  • 16 Rook GA. The hygiene hypothesis and the increasing prevalence of chronic inflammatory disorders. Trans R Soc Trop Med Hyg 2007; 101 (11) 1072-1074
    CrossrefPubMedGoogle Scholar
  • 17 Wlasiuk G, Vercelli D. The farm effect, or: when, what and how a farming environment protects from asthma and allergic disease. Curr Opin Allergy Clin Immunol 2012; 12 (5) 461-466
    CrossrefPubMedGoogle Scholar
  • 18 Foolad N, Brezinski EA, Chase EP, Armstrong AW. Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids. JAMA Dermatol 2013; 149 (3) 350-355
    CrossrefPubMedGoogle Scholar
  • 19 Pelucchi C, Chatenoud L, Turati F , et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 2012; 23 (3) 402-414
    CrossrefPubMedGoogle Scholar
  • 20 Doege K, Grajecki D, Zyriax B-C, Detinkina E, Zu Eulenburg C, Buhling KJ. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood—a meta-analysis. Br J Nutr 2012; 107 (1) 1-6
    CrossrefPubMedGoogle Scholar
  • 21 Braegger C, Chmielewska A, Decsi T , et al; ESPGHAN Committee on Nutrition. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 2011; 52 (2) 238-250
    CrossrefPubMedGoogle Scholar
  • 22 Mugambi MN, Musekiwa A, Lombard M, Young T, Blaauw R. Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review. Nutr J 2012; 11: 58
    CrossrefPubMedGoogle Scholar
  • 23 Mugambi MN, Musekiwa A, Lombard M, Young T, Blaauw R. Synbiotics, probiotics or prebiotics in infant formula for full term infants: a systematic review. Nutr J 2012; 11: 81
    CrossrefPubMedGoogle Scholar
  • 24 Szajewska H, Guandalini S, Morelli L, Van Goudoever JB, Walker A. Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials. J Pediatr Gastroenterol Nutr 2010; 51 (2) 203-209
    CrossrefPubMedGoogle Scholar
  • 25 Wang Q, Dong J, Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg 2012; 47 (1) 241-248
    CrossrefPubMedGoogle Scholar
  • 26 Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011; (3) CD005496
    PubMedGoogle Scholar
  • 27 Downard CD, Renaud E, St Peter SD , et al; 2012 American Pediatric Surgical Association Outcomes Clinical Trials Committee. Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 2012; 47 (11) 2111-2122
    CrossrefPubMedGoogle Scholar
  • 28 Sýkora J, Valecková K, Amlerová J , et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol 2005; 39 (8) 692-698
    CrossrefPubMedGoogle Scholar
  • 29 Szajewska H, Horvath A, Piwowarczyk A. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther 2010; 32 (9) 1069-1079
    CrossrefPubMedGoogle Scholar
  • 30 Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2011; (11) CD004827
    PubMedGoogle Scholar
  • 31 Johnston BC, Ma SSY, Goldenberg JZ , et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 2012; 157 (12) 878-888
    CrossrefPubMedGoogle Scholar
  • 32 Goldenberg JZ, Ma SS, Saxton JD , et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2013; 5 (CD006095): CD006095
    PubMedGoogle Scholar
  • 33 Dinleyici EC, Eren M, Ozen M, Yargic ZA, Vandenplas Y. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 2012; 12 (4) 395-410
    CrossrefPubMedGoogle Scholar
  • 34 Szajewska H, Wanke M, Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther 2011; 34 (9) 1079-1087
    CrossrefPubMedGoogle Scholar
  • 35 Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 2011; 33 (12) 1302-1310
    CrossrefPubMedGoogle Scholar
  • 36 Shen J, Ran HZ, Yin MH, Zhou TX, Xiao DS. Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease. Intern Med J 2009; 39 (2) 103-109
    CrossrefPubMedGoogle Scholar
  • 37 Xu P, Li M, Zhang J, Zhang T. Correlation of intestinal microbiota with overweight and obesity in Kazakh school children. BMC Microbiol 2012; 12: 283
    CrossrefPubMedGoogle Scholar
  • 38 Karlsson CLJ, Onnerfält J, Xu J, Molin G, Ahrné S, Thorngren-Jerneck K. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring) 2012; 20 (11) 2257-2261
    CrossrefPubMedGoogle Scholar
  • 39 Kaplan JL, Walker WA. Early gut colonization and subsequent obesity risk. Curr Opin Clin Nutr Metab Care 2012; 15 (3) 278-284
    CrossrefPubMedGoogle Scholar
  • 40 Smith MI, Yatsunenko T, Manary MJ , et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013; 339 (6119) 548-554
    CrossrefPubMedGoogle Scholar
  • 41 Bruce AW, Chadwick P, Hassan A, VanCott GF. Recurrent urethritis in women. Can Med Assoc J 1973; 108 (8) 973-976
    PubMedGoogle Scholar
  • 42 Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82 (2) 103-108
    CrossrefPubMedGoogle Scholar
  • 43 Lee SJ, Shim YH, Cho SJ, Lee JW. Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol 2007; 22 (9) 1315-1320
    CrossrefPubMedGoogle Scholar
  • 44 Salminen MK, Tynkkynen S, Rautelin H , et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002; 35 (10) 1155-1160
    CrossrefPubMedGoogle Scholar
  • 45 Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115 (1) 178-181
    PubMedGoogle Scholar
  • 46 Coeuret V, Gueguen M, Vernoux JP. Numbers and strains of lactobacilli in some probiotic products. Int J Food Microbiol 2004; 97 (2) 147-156
    CrossrefPubMedGoogle Scholar
  • 47 Drisko J, Bischoff B, Giles C, Adelson M, Rao RV, McCallum R. Evaluation of five probiotic products for label claims by DNA extraction and polymerase chain reaction analysis. Dig Dis Sci 2005; 50 (6) 1113-1117
    CrossrefPubMedGoogle Scholar
  • 48 Elliot E, Teversham K. An evaluation of nine probiotics available in South Africa, August 2003. S Afr Med J 2004; 94 (2) 121-124
    PubMedGoogle Scholar
  • 49 Hamilton-Miller JM, Shah S, Winkler JT. Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr 1999; 2 (2) 223-229
    PubMedGoogle Scholar
  • 50 Huys G, Vancanneyt M, D'Haene K, Vankerckhoven V, Goossens H, Swings J. Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use. Res Microbiol 2006; 157 (9) 803-810
    CrossrefPubMedGoogle Scholar
  • 51 Szajewska H, Fordymacka A, Bardowski J, Górecki RK, Mrukowicz JZ, Banaszkiewicz A. Microbiological and genetic analysis of probiotic products licensed for medicinal purposes. Med Sci Monit 2004; 10 (9) BR346-BR350
    PubMedGoogle Scholar
  • 52 Temmerman R, Scheirlinck I, Huys G, Swings J. Culture-independent analysis of probiotic products by denaturing gradient gel electrophoresis. Appl Environ Microbiol 2003; 69 (1) 220-226
    CrossrefPubMedGoogle Scholar
  • 53 Weese JS. Microbiologic evaluation of commercial probiotics. J Am Vet Med Assoc 2002; 220 (6) 794-797
    CrossrefPubMedGoogle Scholar
  • 54 Weese JS. Evaluation of deficiencies in labeling of commercial probiotics. Can Vet J 2003; 44 (12) 982-983
    PubMedGoogle Scholar
  • 55 Drago L, De Vecchi E, Nicola L, Colombo A, Gismondo MR. Microbiological evaluation of commercial probiotic products available in Italy. J Chemother 2004; 16 (5) 463-467
    PubMedGoogle Scholar
  • 56 Masco L, Huys G, De Brandt E, Temmerman R, Swings J. Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int J Food Microbiol 2005; 102 (2) 221-230
    CrossrefPubMedGoogle Scholar